InvestmentJul 6, 2026, 04:36 PM
China SXT Pharmaceuticals Secures Up to $30M in Financing
AI Summary
China SXT Pharmaceuticals, Inc. has entered into a Securities Purchase Agreement with an institutional investor for Pre-Paid Purchases of its Class A ordinary shares, totaling up to $30,000,000. An initial purchase of $3,150,000 (before OID) is expected on July 6, 2026, with proceeds designated for working capital and corporate purposes. The company also appointed Univest Securities, LLC as the exclusive placement agent for the offering.
Key Highlights
- Secured a Securities Purchase Agreement for up to $30,000,000 in Pre-Paid Purchases.
- Initial Pre-Paid Purchase of $3,150,000 (before $150,000 OID) expected July 6, 2026.
- Proceeds from Pre-Paid Purchases will be used for working capital and corporate purposes.
- Investor can make subsequent purchases up to the $30,000,000 commitment over two years.
- Subsequent Pre-Paid Purchases will have a 5% OID and accrue 7% annual interest.
- Company will file Form F-3 to register resale of Class A Shares within 45 days.
- Investor can purchase Class A Shares at 50% of market price, with a $0.20 floor.
- Univest Securities, LLC appointed as placement agent, receiving a 4.5% cash fee.
Price Impact
More from SXTC